| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.21B | +21.2% |
| Cost of Revenue | $986.2M | +23.3% |
| Gross Profit | $1.22B | +19.6% |
| R&D Expense | $324.7M | +23.2% |
| SG&A Expense | $356.8M | +29.4% |
| Operating Income | $539.4M | +12.0% |
| Pre-tax Income | $572.9M | +13.3% |
| Income Tax | -$1.21B | -1646.9% |
| Net Income | $1.79B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $691.8M | +31.1% |
| Short-term Investments | $171.1M | -70.5% |
| Accounts Receivable | $172.5M | -4.1% |
| Inventory | $419.6M | +9.4% |
| Current Assets | $1.57B | -14.0% |
| Total Assets | $3.62B | +48.6% |
| Current Liabilities | $294.6M | +25.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $788.4M | +23.5% |
| Capital Expenditures | $146.1M | +153.8% |
| Investing Cash Flow | $223.0M | +224.8% |
| Financing Cash Flow | -$872.2M | -374.7% |
| Free Cash Flow | $642.3M | +10.6% |
| +318.1% |
| EPS (Basic) | $36.76 | +309.4% |
| EPS (Diluted) | $36.59 | +317.7% |
| Total Liabilities |
| $471.3M |
| +22.6% |
| Stockholders' Equity | $3.15B | +53.5% |